Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Express Scripts
Boehringer Ingelheim
Fish and Richardson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065275

« Back to Dashboard

NDA 065275 describes IDARUBICIN HYDROCHLORIDE, which is a drug marketed by Fresenius Kabi Usa, Mylan Labs Ltd, Sandoz, Teva Parenteral, West-ward Pharms Int, and Teva Pharms Usa, and is included in seven NDAs. It is available from four suppliers. Additional details are available on the IDARUBICIN HYDROCHLORIDE profile page.

The generic ingredient in IDARUBICIN HYDROCHLORIDE is idarubicin hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Summary for 065275
Applicant:West-ward Pharms Int
Ingredient:idarubicin hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 065275
Mechanism of ActionTopoisomerase Inhibitors
Medical Subject Heading (MeSH) Categories for 065275
Suppliers and Packaging for NDA: 065275
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065275 ANDA West-Ward Pharmaceuticals Corp 0143-9217 0143-9217-01 1 VIAL, GLASS in 1 BOX (0143-9217-01) > 5 mL in 1 VIAL, GLASS
IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065275 ANDA West-Ward Pharmaceuticals Corp 0143-9218 0143-9218-01 1 VIAL, GLASS in 1 BOX (0143-9218-01) > 10 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Dec 14, 2006TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Army
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.